MMA Creates Resource to Help Docs with Treating, Managing Opioid or Substance Use Disorders

April 13, 2023

With the signing of the Consolidated Appropriations Act (CAA) of 2023 last December and the subsequent removal of the DATA Waiver (or X-Waiver) requirement, physicians seeking an initial or a renewed DEA license are required to complete at least eight hours of training for the treatment and management of patients with opioid or other substance use disorders.  

The MMA has created a webpage to help Minnesota physicians comply with this new requirement. 

The deadline for the training is the date of a physician's next scheduled DEA registration submission, whether it is an initial registration or a renewal, on or after June 27, 2023. 

Latest News

Prior Authorization Exemption for Buprenorphine Heard in Senate Committee

April 9, 2026

An amended piece of legislation that would exempt buprenorphine from prior authorization (PA) was heard in the Senate Health and Human Services Committee on April 9. 

Legislation to Expand Collaborative Care Model Heard in Senate HHS Committee

April 9, 2026

On April 9, the Senate Health and Human Services Committee heard a bill that would require coverage for psychiatric Collaborative Care Model (CoCM) services under Medical Assistance.  

House Committee Hears Legislation to Support Hennepin Healthcare System

April 9, 2026

On April 9, the House Taxes Committee heard legislation focused on supporting the financial stability and ongoing operations of Hennepin Healthcare.